$NHHS
NorthStar Healthcare Income, Inc.

2021 Q2 Form 10-Q Financial Statement

#000150370721000034 Filed on August 13, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2
Revenue $63.91M $69.99M
YoY Change -8.69% -6.64%
Cost Of Revenue $45.10M $46.01M
YoY Change -1.98% 3.08%
Gross Profit $18.81M $23.98M
YoY Change -21.58% -20.95%
Gross Profit Margin 29.43% 34.26%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $15.56M $16.50M
YoY Change -5.69% 3.34%
% of Gross Profit 82.72% 68.79%
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $15.96M $16.45M
YoY Change -2.98% -4.86%
% of Operating Profit
Other Income/Expense, Net -$468.0K $0.00
YoY Change
Pretax Income -$17.75M -$105.2M
YoY Change -83.13% 706.89%
Income Tax $11.00K $14.00K
% Of Pretax Income
Net Earnings -$6.998M -$140.0M
YoY Change -95.0% 716.49%
Net Earnings / Revenue -10.95% -200.02%
Basic Earnings Per Share -$0.04 -$0.74
Diluted Earnings Per Share -$0.04 -$0.74
COMMON SHARES
Basic Shares Outstanding 191.3M shares 189.3M shares
Diluted Shares Outstanding 191.3M shares 189.3M shares

Balance Sheet

Concept 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $108.7M $78.40M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill $21.39M $21.39M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $224.7M $231.1M
YoY Change -2.75% -20.01%
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $1.870B $2.023B
YoY Change -7.57% -7.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $1.471B $1.506B
YoY Change -2.36% 1.82%
SHAREHOLDERS EQUITY
Retained Earnings -$1.320B -$1.193B
YoY Change 10.65% 19.29%
Common Stock $1.717B $1.707B
YoY Change 0.57% 0.15%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $396.9M $512.8M
YoY Change
Total Liabilities & Shareholders Equity $1.870B $2.023B
YoY Change -7.57% -7.45%

Cashflow Statement

Concept 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income -$6.998M -$140.0M
YoY Change -95.0% 716.49%
Depreciation, Depletion And Amortization $15.56M $16.50M
YoY Change -5.69% 3.34%
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001503707
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55190
dei Entity Registrant Name
EntityRegistrantName
NORTHSTAR HEALTHCARE INCOME, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-3663988
dei Entity Address Address Line1
EntityAddressAddressLine1
590 Madison Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
34th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10022
dei City Area Code
CityAreaCode
212
dei Local Phone Number
LocalPhoneNumber
547-2600
dei Security12b Title
Security12bTitle
Common stock, par value $0.01 per share
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
191931986 shares
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
108713000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
65995000 USD
CY2021Q2 us-gaap Restricted Cash
RestrictedCash
21637000 USD
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
27575000 USD
CY2021Q2 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
1448040000 USD
CY2020Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
1483930000 USD
CY2021Q2 us-gaap Equity Method Investments
EquityMethodInvestments
224747000 USD
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
229173000 USD
CY2021Q2 us-gaap Mortgage Loans On Real Estate Commercial And Consumer Net
MortgageLoansOnRealEstateCommercialAndConsumerNet
20053000 USD
CY2020Q4 us-gaap Mortgage Loans On Real Estate Commercial And Consumer Net
MortgageLoansOnRealEstateCommercialAndConsumerNet
55864000 USD
CY2021Q2 us-gaap Assets Held For Sale Not Part Of Disposal Group
AssetsHeldForSaleNotPartOfDisposalGroup
0 USD
CY2020Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group
AssetsHeldForSaleNotPartOfDisposalGroup
5000000 USD
CY2021Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
6983000 USD
CY2020Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
14735000 USD
CY2021Q2 nshi Deferred Costs And Intangible Assets Net
DeferredCostsAndIntangibleAssetsNet
25548000 USD
CY2020Q4 nshi Deferred Costs And Intangible Assets Net
DeferredCostsAndIntangibleAssetsNet
26483000 USD
CY2021Q2 us-gaap Other Assets
OtherAssets
14408000 USD
CY2020Q4 us-gaap Other Assets
OtherAssets
9681000 USD
CY2021Q2 us-gaap Assets
Assets
1870129000 USD
CY2020Q4 us-gaap Assets
Assets
1918436000 USD
CY2021Q2 us-gaap Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
4192000 USD
CY2021Q2 us-gaap Notes Payable
NotesPayable
1391309000 USD
CY2020Q4 us-gaap Notes Payable
NotesPayable
1416871000 USD
CY2021Q2 nshi Line Of Credit Related Party
LineOfCreditRelatedParty
35000000 USD
CY2020Q4 nshi Line Of Credit Related Party
LineOfCreditRelatedParty
35000000 USD
CY2021Q2 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
3694000 USD
CY2020Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
8318000 USD
CY2020Q4 us-gaap Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
3851000 USD
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
32745000 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
38393000 USD
CY2021Q2 us-gaap Other Liabilities
OtherLiabilities
3740000 USD
CY2020Q4 us-gaap Other Liabilities
OtherLiabilities
3941000 USD
CY2021Q2 us-gaap Liabilities
Liabilities
1470680000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
1506374000 USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
191694688 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
191694688 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
190409341 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
190409341 shares
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
1916000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
1904000 USD
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1715130000 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1710023000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1320081000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1302755000 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-115000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
467000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
396850000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
409639000 USD
CY2021Q2 us-gaap Minority Interest
MinorityInterest
2599000 USD
CY2020Q4 us-gaap Minority Interest
MinorityInterest
2423000 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
399449000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
412062000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1870129000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1918436000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
28254000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
30698000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
56536000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
63545000 USD
CY2021Q2 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
35612000 USD
CY2020Q2 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
39215000 USD
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
64663000 USD
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
79195000 USD
CY2021Q2 us-gaap Other Operating Income
OtherOperatingIncome
41000 USD
CY2020Q2 us-gaap Other Operating Income
OtherOperatingIncome
79000 USD
us-gaap Other Operating Income
OtherOperatingIncome
42000 USD
us-gaap Other Operating Income
OtherOperatingIncome
143000 USD
CY2021Q2 us-gaap Revenues
Revenues
63907000 USD
CY2020Q2 us-gaap Revenues
Revenues
69992000 USD
us-gaap Revenues
Revenues
121241000 USD
us-gaap Revenues
Revenues
142883000 USD
CY2021Q2 us-gaap Interest Income Debt Securities Operating
InterestIncomeDebtSecuritiesOperating
1387000 USD
CY2020Q2 us-gaap Interest Income Debt Securities Operating
InterestIncomeDebtSecuritiesOperating
1906000 USD
us-gaap Interest Income Debt Securities Operating
InterestIncomeDebtSecuritiesOperating
3600000 USD
us-gaap Interest Income Debt Securities Operating
InterestIncomeDebtSecuritiesOperating
3811000 USD
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
45101000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
46012000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
90719000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
91713000 USD
CY2021Q2 us-gaap Interest Expense
InterestExpense
15962000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
16453000 USD
us-gaap Interest Expense
InterestExpense
31987000 USD
us-gaap Interest Expense
InterestExpense
33132000 USD
CY2021Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 USD
CY2020Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
54000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
7000 USD
CY2021Q2 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
2769000 USD
CY2020Q2 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
4431000 USD
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
5538000 USD
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
8862000 USD
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3079000 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2288000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6112000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5317000 USD
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15557000 USD
CY2020Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16495000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
30944000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
32984000 USD
CY2021Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2020Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
91437000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
786000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
91437000 USD
CY2021Q2 us-gaap Costs And Expenses
CostsAndExpenses
82468000 USD
CY2020Q2 us-gaap Costs And Expenses
CostsAndExpenses
177116000 USD
us-gaap Costs And Expenses
CostsAndExpenses
166140000 USD
us-gaap Costs And Expenses
CostsAndExpenses
263452000 USD
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-468000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6892000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
CY2021Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-111000 USD
CY2020Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
0 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
7404000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
0 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-17753000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-105218000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-27003000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-116758000 USD
CY2021Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
10766000 USD
CY2020Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-34763000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
9876000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-35756000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28000 USD
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-6998000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-139995000 USD
us-gaap Profit Loss
ProfitLoss
-17153000 USD
us-gaap Profit Loss
ProfitLoss
-152542000 USD
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-135000 USD
CY2020Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-714000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
173000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-780000 USD
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6863000 USD
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-139281000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-17326000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-151762000 USD
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.74
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.74
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.80
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.80
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
191273318 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
191273318 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
189336336 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
189336336 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
190953795 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
190953795 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
189187410 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
189187410 shares
CY2021Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
CY2020Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-6998000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-139995000 USD
us-gaap Profit Loss
ProfitLoss
-17153000 USD
us-gaap Profit Loss
ProfitLoss
-152542000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-108000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
186000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-582000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-858000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-108000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
186000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-582000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-858000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-7106000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-139809000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-17735000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-153400000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-135000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-714000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
173000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-780000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6971000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-139095000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17908000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-152620000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
667504000 USD
CY2020Q1 nshi Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees
StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees
2500000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
38000 USD
CY2020Q1 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
86000 USD
CY2020Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
85000 USD
CY2020Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
1998000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1044000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-12547000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
654454000 USD
CY2020Q2 nshi Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees
StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees
2500000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
39000 USD
CY2020Q2 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
7000 USD
CY2020Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
54000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
186000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-139995000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
517137000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
412062000 USD
CY2021Q1 nshi Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees
StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees
2500000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
46000 USD
CY2021Q1 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
240000 USD
CY2021Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
350000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-474000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-10155000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
403869000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
91437000 USD
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
0 USD
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
222000 USD
CY2021Q2 nshi Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees
StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees
2500000 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
73000 USD
CY2021Q2 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
146000 USD
CY2021Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
33000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-108000 USD
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-6998000 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
399449000 USD
us-gaap Profit Loss
ProfitLoss
-17153000 USD
us-gaap Profit Loss
ProfitLoss
-152542000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
9876000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-35756000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
30944000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
32984000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
786000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1575000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1536000 USD
us-gaap Straight Line Rent
StraightLineRent
-7085000 USD
us-gaap Straight Line Rent
StraightLineRent
-70000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
243000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
61000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
932000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
941000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
119000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
77000 USD
nshi Paid In Kind Interest Added To Real Estate Debt Investment Loan Principal
PaidInKindInterestAddedToRealEstateDebtInvestmentLoanPrincipal
194000 USD
nshi Paid In Kind Interest Added To Real Estate Debt Investment Loan Principal
PaidInKindInterestAddedToRealEstateDebtInvestmentLoanPrincipal
0 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
7404000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
0 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-845000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1004000 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
5000000 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
5000000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-1512000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
1282000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
4727000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
298000 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-4624000 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-2332000 USD
nshi Increase Decreasein Escrow Payable
IncreaseDecreaseinEscrowPayable
341000 USD
nshi Increase Decreasein Escrow Payable
IncreaseDecreaseinEscrowPayable
371000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-6210000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4516000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
169000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
34000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2813000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
17433000 USD
nshi Paymentsto Improve Real Estate
PaymentstoImproveRealEstate
10093000 USD
nshi Paymentsto Improve Real Estate
PaymentstoImproveRealEstate
5362000 USD
nshi Proceeds From Sale Of Real Estate Investing
ProceedsFromSaleOfRealEstateInvesting
28078000 USD
nshi Proceeds From Sale Of Real Estate Investing
ProceedsFromSaleOfRealEstateInvesting
0 USD
us-gaap Proceeds From Sale And Collection Of Mortgage Notes Receivable
ProceedsFromSaleAndCollectionOfMortgageNotesReceivable
46631000 USD
us-gaap Proceeds From Sale And Collection Of Mortgage Notes Receivable
ProceedsFromSaleAndCollectionOfMortgageNotesReceivable
0 USD
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
250000 USD
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0 USD
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
3029000 USD
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
1765000 USD
nshi Proceeds From Real Estate Debt Investment Modification Fee
ProceedsFromRealEstateDebtInvestmentModificationFee
559000 USD
nshi Proceeds From Real Estate Debt Investment Modification Fee
ProceedsFromRealEstateDebtInvestmentModificationFee
0 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
290000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
67954000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3887000 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
26000000 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
53361000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
8112000 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
35000000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
708000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
295000 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
307000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1998000 USD
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
386000 USD
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
93000 USD
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
383000 USD
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
139000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-28361000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
24537000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
36780000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
38083000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
93570000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
58820000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
130350000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
96903000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
561000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
500000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0 USD
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
112000 USD
us-gaap Nature Of Operations
NatureOfOperations
Business and Organization<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NorthStar Healthcare Income, Inc., together with its consolidated subsidiaries (the “Company”), manages a diversified portfolio of investments in healthcare real estate, owned directly or through joint ventures, with a focus on the mid-acuity seniors housing sector, which the Company defines as assisted living (“ALF”), memory care (“MCF”), skilled nursing (“SNF”), independent living (“ILF”) facilities and continuing care retirement communities (“CCRC”), which have independent living, assisted living, skilled nursing and memory care available on one campus. Primarily through joint ventures, the Company is also invested in other healthcare property types, including medical office buildings (“MOB”), hospitals, rehabilitation facilities and ancillary healthcare services businesses. The Company’s investments are predominantly in the United States, but through its joint ventures also has international investments in the United Kingdom. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was formed in October 2010 as a Maryland corporation and commenced operations in February 2013. The Company elected to be taxed as a real estate investment trust (“REIT”) under the Internal Revenue Code of 1986, as amended (the “Internal Revenue Code”), commencing with the taxable year ended December 31, 2013. The Company has conducted its operations, and intends to do so in the future, so as to continue to qualify as a REIT for U.S. federal income tax purposes.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of the Company’s business is conducted through NorthStar Healthcare Income Operating Partnership, LP (the “Operating Partnership”). The Company is the sole general partner of the Operating Partnership. The limited partners of the Operating Partnership are NorthStar Healthcare Income Advisor, LLC (the “Prior Advisor”) and NorthStar Healthcare Income OP Holdings, LLC (the “Special Unit Holder”), each an affiliate of the Company’s sponsor. The Prior Advisor invested $1,000 in the Operating Partnership in exchange for common units and the Special Unit Holder invested $1,000 in the Operating Partnership and was issued a separate class of limited partnership units (the “Special Units”), which are collectively recorded as non-controlling interests on the accompanying consolidated balance sheets as of June 30, 2021 and December 31, 2020. As the Company issued shares, it contributed substantially all of the proceeds from its continuous, public offerings to the Operating Partnership as a capital contribution. As of June 30, 2021, the Company’s limited partnership interest in the Operating Partnership was 99.99%.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s charter authorizes the issuance of up to 400.0 million shares of common stock with a par value of $0.01 per share and up to 50.0 million shares of preferred stock with a par value of $0.01 per share. The board of directors of the Company is authorized to amend its charter, without the approval of the stockholders, to increase the aggregate number of authorized shares of capital stock or the number of shares of any class or series that the Company has authority to issue.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is externally managed and has no employees. The Company is sponsored by DigitalBridge Group, Inc. (formerly Colony Capital, Inc.) (NYSE: DBRG) (“DigitalBridge” or the “Sponsor”), a global REIT, that owns, operates and invests across the full spectrum of digital infrastructure and real estate including cell towers, data centers, fiber, small cells and edge infrastructure. Effective June 21, 2021, the Sponsor changed its name from Colony Capital, Inc. to DigitalBridge Group, Inc., and its ticker symbol from “CLNY” to “DBRG.”</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DigitalBridge manages capital on behalf of its stockholders, as well as institutional and retail investors. The Company’s advisor, CNI NSHC Advisors, LLC (the “Advisor”), is a subsidiary of DigitalBridge and manages its day-to-day operations pursuant to an advisory agreement.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From inception through June 30, 2021, the Company raised total gross proceeds from the sale of shares of common stock totaling $2.0 billion (the “Offering”), including $232.6 million pursuant to its distribution reinvestment plan (the “DRP”). </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact of COVID-19</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The world continues to experience the broad effects of the coronavirus 2019 (“COVID-19”) pandemic, with efforts to address the pandemic impacting economic and financial markets globally and across all facets of industries, including real estate. The Company's healthcare real estate business and investments have experienced a myriad of challenges, including, but not limited to, declines in resident occupancy and operating cash flows, increases in cost burden faced by operators, lease concessions sought by tenants, and a stressed market affecting real estate values in general. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recovery from the impact of the COVID-19 pandemic on the Company’s operational and financial performance will depend on a variety of factors, which may differ considerably across regions and fluctuate over time. Recent guidance from state and local governments, including the easing of restrictions, the resumption of normal business operations in many municipalities, and lower reported infection rates are encouraging signs towards a recovery from the effects of the pandemic. Significant vaccine deployment and acceptance has begun to mitigate the number of confirmed COVID-19 cases, which in turn has helped to reduce </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">preventative operating costs that continue to be incurred. However, new strains and variants of the virus have caused a resurgence and an increase in reported infection rates, which may impact the general economic recovery. Occupancy challenges are still anticipated until such time that the rate of resident move-outs is outpaced by new resident admissions, for which the future trend remains uncertain. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company anticipates a recovery of its healthcare real estate business will span over future periods. An extended recovery period increases the risk of a prolonged negative impact on the Company’s financial condition and results of operations. While the Company has the ability to meet its near term liquidity needs, general market concerns over credit and liquidity continue and the effects of COVID-19 may also lead to heightened risk of litigation, with an ensuing increase in litigation and related costs.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At this time, the progression of the global economic recovery from the broad effects of COVID-19 remains difficult for the Company to assess and estimate the future impact of COVID-19 on the Company's results of operations. Accordingly, any estimates of the effects of COVID-19 as reflected and/or discussed in these financial statements are based upon the Company's best estimates using information known to the Company as of the date of this Quarterly Report on Form 10-Q, and such estimates may change, the effects of which could be material. The Company will continue to monitor the progression of the economic recovery from COVID-19 and reassess its effects on the Company’s results of operations and recoverability of value across its assets as conditions change.</span></div>
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000.0 shares
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000.0 shares
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q2 dei Entity Number Of Employees
EntityNumberOfEmployees
0 employee
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2000000000.0 USD
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reclassifications</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period amounts have been reclassified on the consolidated statements of cash flows from the supplemental disclosure of non-cash investing and financing activities to adjustments to reconcile net income (loss) to net cash provided by operating activities to conform to current period presentation.</span></div>
CY2021Q2 us-gaap Equity Method Investments
EquityMethodInvestments
224700000 USD
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
300000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Estimates</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that could affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates and assumptions. Any estimates of the effects of COVID-19 as reflected and/or discussed in these financial statements are based upon the Company's best estimates using information known to the Company as of the date of this Quarterly Report on Form 10-Q. Such estimates may change and the impact of which could be material.</span></div>
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
108713000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
65995000 USD
CY2021Q2 us-gaap Restricted Cash
RestrictedCash
21637000 USD
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
27575000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
130350000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
93570000 USD
CY2021Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
3400000 USD
nshi Finance Lease Payments
FinanceLeasePayments
300000 USD
nshi Finance Lease Payments
FinanceLeasePayments
300000 USD
CY2021Q2 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
322000 USD
CY2021Q2 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
560000 USD
CY2021Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
138000 USD
CY2021Q2 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
42000 USD
CY2021Q2 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
0 USD
CY2021Q2 nshi Finance Lease Liability To Be Paid After Year Four
FinanceLeaseLiabilityToBePaidAfterYearFour
0 USD
CY2021Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
1062000 USD
CY2021Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
58000 USD
CY2021Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
1004000 USD
CY2021Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.061
CY2021Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y9M18D
CY2021Q2 nshi Number Of Properties Sold
NumberOfPropertiesSold
2 property
CY2021Q2 us-gaap Finite Lived Intangible Asset Acquired In Place Leases
FiniteLivedIntangibleAssetAcquiredInPlaceLeases
3735000 USD
CY2020Q4 us-gaap Finite Lived Intangible Asset Acquired In Place Leases
FiniteLivedIntangibleAssetAcquiredInPlaceLeases
4635000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
21387000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
21387000 USD
CY2021Q2 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
380000 USD
CY2020Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
380000 USD
CY2021Q2 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
25502000 USD
CY2020Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
26402000 USD
CY2021Q2 us-gaap Deferred Costs Leasing Net
DeferredCostsLeasingNet
46000 USD
CY2020Q4 us-gaap Deferred Costs Leasing Net
DeferredCostsLeasingNet
81000 USD
CY2021Q2 nshi Deferred Costs And Intangible Assets Net
DeferredCostsAndIntangibleAssetsNet
25548000 USD
CY2020Q4 nshi Deferred Costs And Intangible Assets Net
DeferredCostsAndIntangibleAssetsNet
26483000 USD
CY2021Q2 nshi Amortizationof Deferred Costsand Intangible Assets
AmortizationofDeferredCostsandIntangibleAssets
500000 USD
nshi Amortizationof Deferred Costsand Intangible Assets
AmortizationofDeferredCostsandIntangibleAssets
500000 USD
nshi Amortizationof Deferred Costsand Intangible Assets
AmortizationofDeferredCostsandIntangibleAssets
900000 USD
CY2020Q2 nshi Amortizationof Deferred Costsand Intangible Assets
AmortizationofDeferredCostsandIntangibleAssets
900000 USD
CY2021Q2 nshi Deferred Costsand Finite Lived Intangible Assets Amortization Expense Remainderof Fiscal Year
DeferredCostsandFiniteLivedIntangibleAssetsAmortizationExpenseRemainderofFiscalYear
937000 USD
CY2021Q2 nshi Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year One
DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearOne
592000 USD
CY2021Q2 nshi Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year Two
DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
337000 USD
CY2021Q2 nshi Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year Three
DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearThree
337000 USD
CY2021Q2 nshi Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year Four
DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearFour
337000 USD
CY2021Q2 nshi Deferred Costs And Finite Lived Intangible Assets Amortization Expense After Year Four
DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
1241000 USD
CY2021Q2 nshi Deferred Costsand Finite Lived Intangible Assets Net
DeferredCostsandFiniteLivedIntangibleAssetsNet
3781000 USD
CY2021Q2 nshi Healthcare Facility Regulatory Reserve
HealthcareFacilityRegulatoryReserve
6000000 USD
CY2020Q4 nshi Healthcare Facility Regulatory Reserve
HealthcareFacilityRegulatoryReserve
0 USD
CY2021Q2 nshi Ownership Interestin Condominiums
OwnershipInterestinCondominiums
2327000 USD
CY2020Q4 nshi Ownership Interestin Condominiums
OwnershipInterestinCondominiums
2327000 USD
CY2021Q2 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
2611000 USD
CY2020Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
3798000 USD
CY2021Q2 us-gaap Incentive To Lessee
IncentiveToLessee
2663000 USD
CY2020Q4 us-gaap Incentive To Lessee
IncentiveToLessee
2246000 USD
CY2021Q2 nshi Utility Deposit Assets
UtilityDepositAssets
450000 USD
CY2020Q4 nshi Utility Deposit Assets
UtilityDepositAssets
447000 USD
CY2021Q2 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
357000 USD
CY2020Q4 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
863000 USD
CY2021Q2 us-gaap Other Assets
OtherAssets
14408000 USD
CY2020Q4 us-gaap Other Assets
OtherAssets
9681000 USD
CY2021Q2 nshi Lease Terms Days Notice Required For Termination
LeaseTermsDaysNoticeRequiredForTermination
30 D
CY2021Q2 nshi Lease Terms Days Notice Required For Termination
LeaseTermsDaysNoticeRequiredForTermination
30 D
CY2021Q2 us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
3400000 USD
CY2020Q2 us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
4000000.0 USD
us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
6700000 USD
us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
8200000 USD
nshi Lessor Concession Granted Period Covid19
LessorConcessionGrantedPeriodCOVID19
P90D
nshi Lessor Concession Granted Repayment Period Covid19
LessorConcessionGrantedRepaymentPeriodCOVID19
P12M
CY2021Q2 nshi Lessor Concession Granted Payments Deferred Covid19
LessorConcessionGrantedPaymentsDeferredCOVID19
500000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
800000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
91400000 USD
us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0 USD
us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
37400000 USD
CY2021Q2 nshi Acquisition Feeand Expense Cap
AcquisitionFeeandExpenseCap
0.060
CY2021Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
22200000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28000 USD
CY2021Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
108079000 USD
CY2021Q2 us-gaap Tenant Improvements
TenantImprovements
17173000 USD
CY2020Q4 us-gaap Tenant Improvements
TenantImprovements
16172000 USD
CY2021Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
4685000 USD
CY2020Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
2535000 USD
CY2021Q2 us-gaap Land
Land
229581000 USD
CY2020Q4 us-gaap Land
Land
234706000 USD
CY2021Q2 us-gaap Land Improvements
LandImprovements
23470000 USD
CY2020Q4 us-gaap Land Improvements
LandImprovements
23797000 USD
CY2021Q2 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
1377045000 USD
CY2020Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
1389706000 USD
CY2020Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
108055000 USD
CY2021Q2 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
1760033000 USD
CY2020Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
1774971000 USD
CY2021Q2 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
311993000 USD
CY2020Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
291041000 USD
CY2021Q2 us-gaap Real Estate Investments
RealEstateInvestments
1448040000 USD
CY2020Q4 us-gaap Real Estate Investments
RealEstateInvestments
1483930000 USD
CY2021Q2 us-gaap Depreciation
Depreciation
15100000 USD
us-gaap Depreciation
Depreciation
30000000.0 USD
CY2020Q2 us-gaap Depreciation
Depreciation
16000000.0 USD
us-gaap Depreciation
Depreciation
32000000.0 USD
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
800000 USD
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
91400000 USD
CY2021Q2 us-gaap Equity Method Investments
EquityMethodInvestments
224747000 USD
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
229173000 USD
CY2019Q1 us-gaap Proceeds From Sale Of Property Held For Sale
ProceedsFromSaleOfPropertyHeldForSale
118000000.0 USD
CY2019Q1 nshi Equity Method Investment Numberof Facilities Sold
EquityMethodInvestmentNumberofFacilitiesSold
11 facility
CY2019Q1 nshi Proceeds From Sale Of Property Held For Sale Net
ProceedsFromSaleOfPropertyHeldForSaleNet
4300000 USD
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
300000 USD
CY2021Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
10766000 USD
CY2021Q2 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
2170000 USD
CY2020Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-34763000 USD
CY2020Q2 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
0 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
9876000 USD
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
3029000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-35756000 USD
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
1765000 USD
us-gaap Proceeds From Sale And Collection Of Mortgage Notes Receivable
ProceedsFromSaleAndCollectionOfMortgageNotesReceivable
46600000 USD
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
14601000 USD
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
478740000 USD
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
19696000 USD
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
20406000 USD
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
670302000 USD
CY2021Q2 nshi Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
204276000 USD
CY2021Q2 us-gaap Long Term Debt
LongTermDebt
1408021000 USD
CY2021Q2 nshi Debt Instrument Principal Deferred Covid19
DebtInstrumentPrincipalDeferredCOVID19
1300000000 USD
CY2021Q2 nshi Debt Instrument Deferred Debt Service Covid19
DebtInstrumentDeferredDebtServiceCOVID19
3100000 USD
CY2020Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
8318000 USD
nshi Related Party Transaction Dueto Related Parties Amount Incurred
RelatedPartyTransactionDuetoRelatedPartiesAmountIncurred
11198000 USD
nshi Related Party Transaction Dueto Related Parties Amount Paid
RelatedPartyTransactionDuetoRelatedPartiesAmountPaid
15822000 USD
CY2021Q2 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
3694000 USD
nshi Noncashor Part Noncash Acquisition Noncash Financialor Equity Instrument Consideration Shares Issuedas Paymentfor Asset Management Fees
NoncashorPartNoncashAcquisitionNoncashFinancialorEquityInstrumentConsiderationSharesIssuedasPaymentforAssetManagementFees
5000000.0 USD
nshi Stock Redeemedor Called During Period Shares Paymentof Advisor Asset Management Fees
StockRedeemedorCalledDuringPeriodSharesPaymentofAdvisorAssetManagementFees
1300000 shares
nshi Noncashor Part Noncash Acquisition Noncash Financialor Equity Instrument Consideration Shares Issuedas Paymentfor Asset Management Fees
NoncashorPartNoncashAcquisitionNoncashFinancialorEquityInstrumentConsiderationSharesIssuedasPaymentforAssetManagementFees
5000000.0 USD
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
73208 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
39542 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
118833 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
77667 USD
CY2021Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
334417 USD
CY2020Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
193250 USD
CY2019Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
86000000.0 USD
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-100000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
200000 USD
CY2020Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-700000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-800000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
5 segment
CY2021Q2 nshi Rentaland Resident Fee Income
RentalandResidentFeeIncome
63907000 USD
CY2021Q2 us-gaap Interest Income Operating
InterestIncomeOperating
1387000 USD
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
45101000 USD
CY2021Q2 us-gaap Interest Expense
InterestExpense
15962000 USD
CY2021Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 USD
CY2021Q2 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
2769000 USD
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3079000 USD
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15557000 USD
CY2021Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-468000 USD
CY2021Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-111000 USD
CY2021Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
10766000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11000 USD
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-6998000 USD
CY2020Q2 nshi Rentaland Resident Fee Income
RentalandResidentFeeIncome
69992000 USD
CY2020Q2 us-gaap Interest Income Operating
InterestIncomeOperating
1906000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
46012000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
16453000 USD
CY2020Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 USD
CY2020Q2 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
4431000 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2288000 USD
CY2020Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16495000 USD
CY2020Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
91437000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
CY2020Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
0 USD
CY2020Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-34763000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-139995000 USD
nshi Rentaland Resident Fee Income
RentalandResidentFeeIncome
121241000 USD
us-gaap Interest Income Operating
InterestIncomeOperating
3600000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
90719000 USD
us-gaap Interest Expense
InterestExpense
31987000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
54000 USD
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
5538000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6112000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
30944000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
786000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6892000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
7404000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
9876000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26000 USD
us-gaap Profit Loss
ProfitLoss
-17153000 USD
nshi Rentaland Resident Fee Income
RentalandResidentFeeIncome
142883000 USD
us-gaap Interest Income Operating
InterestIncomeOperating
3811000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
91713000 USD
us-gaap Interest Expense
InterestExpense
33132000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
7000 USD
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
8862000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5317000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
32984000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
91437000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
0 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-35756000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28000 USD
us-gaap Profit Loss
ProfitLoss
-152542000 USD
CY2021Q2 us-gaap Assets
Assets
1870129000 USD
CY2020Q4 us-gaap Assets
Assets
1918436000 USD
CY2021Q2 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
71 property
CY2021Q2 us-gaap Number Of Units In Real Estate Property
NumberOfUnitsInRealEstateProperty
10118 unit
us-gaap Noninterest Income
NoninterestIncome
121241000 USD
CY2021Q2 nshi Number Of Properties Sold
NumberOfPropertiesSold
2 property

Files In Submission

Name View Source Status
0001503707-21-000034-index-headers.html Edgar Link pending
0001503707-21-000034-index.html Edgar Link pending
0001503707-21-000034.txt Edgar Link pending
0001503707-21-000034-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nshi-20210630.htm Edgar Link pending
nshi-20210630.xsd Edgar Link pending
nshi-20210630_cal.xml Edgar Link unprocessable
nshi-20210630_def.xml Edgar Link unprocessable
nshi-20210630_g1.jpg Edgar Link pending
nshi-20210630_g2.jpg Edgar Link pending
nshi-20210630_htm.xml Edgar Link completed
nshi-20210630_lab.xml Edgar Link unprocessable
nshi-20210630_pre.xml Edgar Link unprocessable
nshi06302021exhibit311.htm Edgar Link pending
nshi06302021exhibit312.htm Edgar Link pending
nshi06302021exhibit321.htm Edgar Link pending
nshi06302021exhibit322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending